Bio-Techne Corporation
TECHNASDAQHealthcare● Active
$51.99
$-1.19(-2.24%)
Market Cap$8.1B
P/E Ratio—
52W High$72.16
52W Low$43.2
Bio-Techne Corporation (TECH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TECH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.53
Est. $0.55 · -3.6%
Revenue
$0.31B
Est. $0.32B · -1.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
TECH reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $0.53 | — | — | — | $0.31B | — |
| ▼ Q2 FY2026 | May 6, 2026 | $0.55 | $0.53 | -3.6% | $0.31B | $0.32B | -1.5% |
| ▲ Q1 FY2026 | Feb 4, 2026 | $0.43 | $0.46 | +7.0% | $0.30B | $0.29B | +1.9% |
| — Q4 FY2025 | Nov 5, 2025 | $0.42 | $0.42 | -0.3% | $0.29B | $0.29B | -1.6% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $0.50 | $0.53 | +6.1% | $0.32B | $0.29B | +7.6% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.51 | $0.56 | +10.2% | $0.32B | $0.33B | -2.9% |
| ▲ Q1 FY2025 | Feb 5, 2025 | $0.39 | $0.42 | +8.8% | $0.30B | $0.32B | -6.5% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.38 | $0.42 | +10.5% | $0.29B | $0.28B | +3.3% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$0.53
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
$0.53
EPS Est.
$0.55
EPS Surpr.
-3.6%
Revenue
$0.31B
Q1 FY2026
Feb 4, 2026Beat
EPS Actual
$0.46
EPS Est.
$0.43
EPS Surpr.
+7.0%
Revenue
$0.30B
Q4 FY2025
Nov 5, 2025
EPS Actual
$0.42
EPS Est.
$0.42
EPS Surpr.
-0.3%
Revenue
$0.29B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.53
EPS Est.
$0.50
EPS Surpr.
+6.1%
Revenue
$0.32B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.56
EPS Est.
$0.51
EPS Surpr.
+10.2%
Revenue
$0.32B
Q1 FY2025
Feb 5, 2025Beat
EPS Actual
$0.42
EPS Est.
$0.39
EPS Surpr.
+8.8%
Revenue
$0.30B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.42
EPS Est.
$0.38
EPS Surpr.
+10.5%
Revenue
$0.29B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.66 | $0.67 | $0.68 | 2 |
| Q1 FY2028 | $0.64 | $0.65 | $0.67 | 3 |
| Q4 FY2027 | $0.55 | $0.56 | $0.57 | 2 |
| Q3 FY2027 | $0.50 | $0.51 | $0.52 | 1 |
| Q2 FY2027 | $0.56 | $0.57 | $0.58 | 1 |
| Q1 FY2027 | $0.55 | $0.56 | $0.57 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.3B | $0.4B | $0.4B | 1 |
| Q1 FY2028 | $0.3B | $0.3B | $0.4B | 1 |
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q1 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -3.6% | $56.68 | $47.41 | -16.35% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +7.0% | $64.63 | $68.67 | +6.25% |
| ▲ Q4 FY2025 | Nov 5, 2025 | -0.3% | $61.10 | $59.94 | -1.90% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +6.1% | $54.64 | $49.87 | -8.73% |
| ▲ Q2 FY2025 | May 7, 2025 | +10.2% | $47.72 | $48.75 | +2.16% |
| ▲ Q1 FY2025 | Feb 5, 2025 | +8.8% | $72.55 | $75.25 | +3.72% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +10.5% | $70.74 | $76.02 | +7.46% |
| ▲ Q3 FY2024 | Aug 7, 2024 | -1.0% | $78.42 | $70.96 | -9.51% |
Q2 FY2026-16.35%
Report Date
May 6, 2026
EPS Beat/Miss
-3.6%
Price Before
$56.68
Price After
$47.41
Q1 FY2026+6.25%
Report Date
Feb 4, 2026
EPS Beat/Miss
+7.0%
Price Before
$64.63
Price After
$68.67
Q4 FY2025-1.90%
Report Date
Nov 5, 2025
EPS Beat/Miss
-0.3%
Price Before
$61.10
Price After
$59.94
Q3 FY2025-8.73%
Report Date
Aug 6, 2025
EPS Beat/Miss
+6.1%
Price Before
$54.64
Price After
$49.87
Q2 FY2025+2.16%
Report Date
May 7, 2025
EPS Beat/Miss
+10.2%
Price Before
$47.72
Price After
$48.75
Q1 FY2025+3.72%
Report Date
Feb 5, 2025
EPS Beat/Miss
+8.8%
Price Before
$72.55
Price After
$75.25
Q4 FY2024+7.46%
Report Date
Oct 30, 2024
EPS Beat/Miss
+10.5%
Price Before
$70.74
Price After
$76.02
Q3 FY2024-9.51%
Report Date
Aug 7, 2024
EPS Beat/Miss
-1.0%
Price Before
$78.42
Price After
$70.96
Avg Beat Reaction-0.08%
Avg Miss Reaction-16.35%
Beat Rate7 / 8 quarters
Largest Move-16.35% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TECH ends December
Bio-Techne Corporation (TECH) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.53 — missing the analyst consensus of $0.55 by -3.6%. The next TECH earnings date is expected around September 1, 2026.
Each quarter, investors track TECH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TECH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TECH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TECH earnings · 5 questionsBio-Techne Corporation's next earnings report is expected around September 1, 2026. TECH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TECH historically reports after market close (AMC).
TECH earnings datewhen is TECH earningsTECH next earnings datewhen does TECH report earningsTECH earnings calendar
▸ Source: FMP · Bio-Techne Corporation SEC filings · US GAAP · Bio-Techne Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026